Metabolic Acidosis in Renal Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Renal Transplant PatientsMetabolic AcidosisPhysical CapacityBone DiseaseMineral Metabolism
Interventions
DRUG

Potassium citrate

2.41 gram of citrate b.i.d. for 12 months. Dosage to be adjusted according to serum potassium concentration.

DRUG

Potassium chloride

370 mg potassium t.i.d. for 12 months. Dosage to be adjusted according to serum postassium concentration.

Trial Locations (1)

CH 8091

University Hospital of Zurich, Zurich

All Listed Sponsors
collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

Swiss Federal Institute of Technology

OTHER

lead

University of Zurich

OTHER

NCT00913796 - Metabolic Acidosis in Renal Transplant Patients | Biotech Hunter | Biotech Hunter